Sort
10,766 grants matching “checkpoint inhibitor”
Targeting the host NDP kinase to abrogate viral dissemination
$62,715Chengyu Liang · University Of Southern California · R21 · FY2020 · DE
Cancer Center Support Grant
$62,000Benjamin G. Neel · New York University School Of Medicine · P30 · FY2021 · CA
The replication checkpoint and genomic fidelity in skin
$61,965Massachusetts General Hospital · K02 · FY2005 · AR
Delineating the role of SPP1+ macrophages in colorectal cancer metastasis
$61,760Melanie Hayden Gephart · Stanford University · U54 · FY2024 · CA
Project 05: Translational Therapeutics (TT)
$61,572David P Carbone · Ohio State University · P30 · FY2021 · CA
Immunology and Cancer Immunotherapy (ICI)
$61,338Mary J Turk · Dartmouth College · P30 · FY2022 · CA
Immunology and Cancer Immunotherapy (ICI)
$61,338Mary J Turk · Dartmouth College · P30 · FY2023 · CA
Immunology and Cancer Immunotherapy (ICI)
$61,338Mary J Turk · Dartmouth College · P30 · FY2020 · CA
Immunology and Cancer Immunotherapy (ICI)
$61,338Mary J Turk · Dartmouth College · P30 · FY2021 · CA
Immunology and Cancer Immunotherapy (ICI)
$61,336Mary J Turk · Dartmouth College · P30 · FY2024 · CA
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.
$61,226Jennifer E Klomp · Univ Of North Carolina Chapel Hill · F32 · FY2019 · CA
Alleviating solid stress to overcome immunotherapy resistance in metastatic breast cancer
$60,990Hadi Tavakoli Nia · Massachusetts General Hospital · F32 · FY2017 · CA
Exploration of Tumor-Intrinsic NLRP3 Signaling Regulators
$60,897Brent Allen Hanks · Duke University · R37 · FY2021 · CA
Regulation of Replication Checkpoint by Proteolysis
$60,873Hui Zhang · Yale University · R01 · FY2007 · CA
Nanomaterials for eliciting anti-tumor T-cells-Diversity Supplement
$60,840James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Mechanism of APE1 in DNA damage response
$60,762Shan Yan · University Of North Carolina Charlotte · R01 · FY2022 · CA
Project 05: Translational Therapeutics (TT)
$60,535David P Carbone · Ohio State University · P30 · FY2025 · CA
SCAR 2025: Stronger Together
$60,000Elizabeth Phillips · Vanderbilt University Medical Center · R13 · FY2025 · AR
Mechanisms that coordinate cell size with mitotic entry
$60,000James B Moseley · Dartmouth College · R01 · FY2015 · GM
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$59,901Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Development of Preventive Strategies and Therapy for HIV Infection
$59,835Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer
$59,382Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2022 · CA
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology
$59,311Anil Shanker · Meharry Medical College · U54 · FY2022 · CA
The Role of Tumor Induced PD-L1 Expression on Myeloid Cells in GBM on Expansion of Regulatory T Cells and Systemic Immunosuppression
$59,166Gurvinder Kaur · Northwestern University At Chicago · F32 · FY2017 · NS
The Role of Glioma Metabolism in Promoting Tumor Immunosuppression
$59,166Jason Miska · Northwestern University At Chicago · F32 · FY2017 · NS